Response
The issue of whether structural or functional abnormalities underlie the syndrome of right bundle-branch block, right precordial ST-segment elevation, and sudden death raised by Drs Martini et al is obviously of great importance. As indicated in our article, 1 it is no surprise that the authors stress the importance of the causal presence of (concealed) heart muscle disease. Indeed, their thoroughly studied families (family?) show evidence of right ventricular cardiomyopathy. 2 We therefore excluded (and did not ignore) these patients from additional analysis. However, the available clinical data of the remaining 163 patients (echocardiogram, left and right ventricular angiography, ergometry, and biopsy samples available in 96%, 49%, 40%, and 20% of the patients, respectively) show no evidence of structural heart disease. By definition, concealed heart muscle disease is not excluded.
For the diagnosis of Brugada syndrome, we emphasized the presence of a dynamic ST segment that seems not to be present in the northern Italian family. Indeed, on the basis of inflammatory or degenerative heart disease, such dynamicity is not to be expected. Genetically altered ionic currents may, however, be more sensitive to modulating factors, such as the autonomic nervous system, and explain day-to-day variability. Also, the (predictable) response to various drugs seems a more logical consequence of a functional rather than of a structural defect. For the growing number of patients with drug-induced J-point elevation, this hypothesis remains to be proven. 3 Without doubt, before the diagnosis is made, extensive clinical investigation should be directed to exclude any structural disorder, even in patients with established SCN5A mutations. 1 However, we hope that Drs Martini et al no longer ignore the existence of a functional disorder underlying the syndrome of right bundle-branch block, right precordial ST-segment elevation, and sudden death.
